Of nanobacteria, nanoparticles, biofilms and their role in health and disease: facts, fancy and future

Author:

Martel Jan12,Peng Hsin-Hsin12,Young David134,Wu Cheng-Yeu125,Young John D1267

Affiliation:

1. Laboratory of Nanomaterials, Chang Gung University, Gueishan, Taoyuan 333, Taiwan

2. Center for Molecular & Clinical Immunology, Chang Gung University, Gueishan, Taoyuan 333, Taiwan

3. Department of Materials Science & Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

4. Primordia Institute of New Sciences & Medicine, Florham Park, NJ 07932, USA

5. Research Center of Bacterial Pathogenesis, Chang Gung University, Gueishan, Taoyuan 333, Taiwan

6. Laboratory of Cellular Physiology & Immunology, The Rockefeller University, New York, NY 10021, USA

7. Biochemical Engineering Research Center, Ming Chi University of Technology, Taishan, Taipei 24301, Taiwan

Abstract

Nanobacteria have been at the center of a major scientific controversy in recent years owing to claims that they represent not only the smallest living microorganisms on earth but also new emerging pathogens associated with several human diseases. We and others have carefully examined these claims and concluded that nanobacteria are in fact nonliving mineralo-organic nanoparticles (NPs) that form spontaneously in body fluids. We have shown that these mineral particles possess intriguing biomimetic properties that include the formation of cell- and tissue-like morphologies and the possibility to grow, proliferate and propagate by subculture. Similar mineral NPs (bions) have now been found in both physiological and pathological calcification processes and they appear to represent precursors of physiological calcification cycles, which may at times go awry in disease conditions. Furthermore, by functioning at the nanoscale, these mineralo-organic NPs or bions may shed light on the fate of nanomaterials in the body, from both nanotoxicological and nanopathological perspectives.

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3